# Micro-Particle Curcumin for the Treatment of Chronic Kidney Disease

> **NCT02369549** · PHASE3 · COMPLETED · sponsor: **London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's** · enrollment: 518 (actual)

## Conditions studied

- Chronic Kidney Disease

## Interventions

- **DRUG:** Micro-particle Curcumin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02369549
- **Lead sponsor:** London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2019-11
- **Final completion:** 2020-05-15
- **Target enrollment:** 518 (ACTUAL)
- **Last updated:** 2021-01-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02369549

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02369549, "Micro-Particle Curcumin for the Treatment of Chronic Kidney Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02369549. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*